EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic features.

Wang S, Tan C, Shi P, Li Y, Zhan H, Li J

Open source

DOI
10.3389/fphar.2026.1935622
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1935622,
  title = {EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic features.},
  author = {Wang S and Tan C and Shi P and Li Y and Zhan H and Li J},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1935622},
  url = {https://doi.org/10.3389/fphar.2026.1935622}
}

RIS

TY  - JOUR
TI  - EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic features.
AU  - Wang S
AU  - Tan C
AU  - Shi P
AU  - Li Y
AU  - Zhan H
AU  - Li J
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1935622
UR  - https://doi.org/10.3389/fphar.2026.1935622
ER  - 

APA

S, W., C, T., P, S., Y, L., H, Z., & J, L. (2026). EGFR-TKI-associated colitis in non-small cell lung cancer: a retrospective characterization of clinical, radiographic, endoscopic, and histopathologic features.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1935622

Source records